This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.
The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.
The future of medicine is being redefined by artificial intelligence. From digital twins and precision medicine to AI-driven medical imaging and large language models, cutting-edge technologies are transforming the way we diagnose, treat, and prevent disease.
14 July 2025
Sleep disturbances in breast cancer patients undergoing neoadjuvant chemotherapy – designed to shrink the tumours prior to surgery – are one of the common side effects of these treatments, which can not only exacerbate other side effects, but also impact prognosis. One of the possible, non-pharmacological strategies to mitigate these disturbances is thought to be physical exercise.
09 July 2025
Following Episode 5 - Part 1, where we explored the hidden world of the hypothalamus and the “love hormone” oxytocin, this second part of Hedi’s conversation with neuroendocrinologist Gareth Leng takes us even deeper.
25 June 2025
From the “love hormone” and maternal bonding, to why your brain is more like a quantum computer, discover the brain’s secret hormonal languages that drive your behaviour and keep you alive in Episode 5 (Part 1).
Date and Time
22 September 2025, 2pm - 7:45pm
Location
Auditorium, Champalimaud Foundation, Lisbon
Topic
This conference will discuss the prevention, treatment and challenges of gynaecological, testicular and prostate cancers with leading experts in the field.
Presented by Fernanda Freitas
2:00pm – 2:10pm – Opening Session
17 June 2025
The results of the most recent European Research Council (ERC) Advanced Grants have been announced today (June 17th). In Portugal, the ERC selected two new projects in the area of life sciences, which in total will receive 5M€.
The ERC funding, worth in total €721M, will go to 281 leading researchers across Europe. In the case of life sciences, 732 proposals were submitted and 83 were selected for funding, which represents a success rate of approximately 11%.